Research LetterPalliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trial
References (5)
- et al.
Palliative care in heart failure: the PAL-HF randomized, controlled clinical trial
J Am Coll Cardiol
(2017) - et al.
Palliative care in heart failure: rationale, evidence, and future priorities
J Am Coll Cardiol
(2017)
Cited by (15)
Shaping the gut microbiota by bioactive phytochemicals: An emerging approach for the prevention and treatment of human diseases
2022, BiochimieCitation Excerpt :Upon metabolism of trimethylamine derivatives by microbial TMA lyases produce TMA, which will further be oxidized to TMAO by hepatic flavinmonooxygenases and consequently enters the general circulation [135]. Studies suggest that elevated levels of TMAO have been used as a predictor of mortality risk in patients with chronic and acute heart failure [149]. CVD risks are more in people with consumption of animal products (contains more TMAO-producing nutrients) than vegetarians, where TMAO shows cardioprotective effects [150].
The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial
2021, Journal of Cardiac FailureThe Many Faces of Heart Failure
2019, Cardiac Electrophysiology ClinicsCitation Excerpt :Patients with HF may be candidates for advanced therapies, including cardiac transplantation and ventricular assist devices, yet these therapies may not be applicable to all patients. Recent data demonstrate a trend toward palliative care service utilization in the last year of life in patients with HF, highlighting the importance of a patient-centered approach in management that focuses on symptom relief.53,54 HF is an increasingly prevalent clinical syndrome marked by congestion and fatigue and associated with reduced quality of life and survival.
Effects of Buyang Huanwu Decoction on Intestinal Barrier, Intestinal Flora, and Trimethylamine Oxide in Rats with Heart Failure
2023, Chinese Journal of Integrative Medicine
Larry A. Allen, MD, MHS, served as guest editor for this article.
Funding: PAL-HF was funded by the National Institute of Nursing Research (R01NR013428). R. J. M. receives research support from the NIH (U10HL110312, R01AG045551-01A1). K. J. received research support from projects funded by the NIA (RO1AG042130; K08AG028975).
Disclosures: The authors report no relevant disclosures.